Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Clinical News

NNZ-2566: Phase II data

December 8, 2014 8:00 AM UTC

Top-line data from a double-blind, placebo-controlled, U.S. Phase II trial in 53 female Rett syndrome patients ages 16-45 showed that twice-daily 35 and 70 mg/kg doses of oral NNZ-2566 for up to 28 da...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article